Decoy Therapeutics (DCOY) Accounts Payables (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Accounts Payables of $936030.0 for Q1 2026, down 36.35% year-over-year from $1.5 million in Q1 2025, and little changed quarter-over-quarter from $940586.0 in Q4 2025.
Decoy Therapeutics (DCOY) Accounts Payables (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Accounts Payables for 13 consecutive years, with $936030.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 36.35% year-over-year to $936030.0; the TTM figure through Mar 2026 stood at $936030.0 (down 36.35% YoY), while the FY2025 annual figure was $940586.0, changed 0.38% from the prior year.
- Accounts Payables steadied at $936030.0 in Q1 2026 per DCOY's latest filing, from $940586.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $3.5 million in Q1 2023 and bottomed at $165801.0 in Q3 2024.
- Historically, Accounts Payables has averaged $1.4 million across 5 years, with a median of $1.1 million in 2025.
- Annual changes were most pronounced in 2024 — Accounts Payables plunged 84.77% — and 2025, when it soared 565.97%.
- Decoy Therapeutics' Accounts Payables stood at $2.9 million in 2022, then sank by 78.91% to $602853.0 in 2023, then soared by 55.43% to $936994.0 in 2024, then climbed by 0.38% to $940586.0 in 2025, then dropped by 0.48% to $936030.0 in 2026.
- Business Quant data shows DCOY's Accounts Payables at $936030.0 in Q1 2026, $940586.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | 936,030.00 |
| Dec 31, 2025 | 940,586.00 |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 936,994.00 |
| Sep 30, 2024 | 165,801.00 |
| Jun 30, 2024 | 643,051.00 |
| Mar 31, 2024 | 713,957.00 |
| Dec 31, 2023 | 602,853.00 |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 2.86 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.87 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 1.54 Mn |
| Sep 30, 2021 | 1.23 Mn |